Literature DB >> 33718406

Evaluation of an Automatic Classification Algorithm Using Convolutional Neural Networks in Oncological Positron Emission Tomography.

Pierre Pinochet1, Florian Eude1, Stéphanie Becker1,2, Vijay Shah3, Ludovic Sibille3, Mathieu Nessim Toledano1, Romain Modzelewski1,2, Pierre Vera1,2, Pierre Decazes1,2.   

Abstract

Introduction: Our aim was to evaluate the performance in clinical research and in clinical routine of a research prototype, called positron emission tomography (PET) Assisted Reporting System (PARS) (Siemens Healthineers) and based on a convolutional neural network (CNN), which is designed to detect suspected cancer sites in fluorine-18 fluorodeoxyglucose (18F-FDG) PET/computed tomography (CT). Method: We retrospectively studied two cohorts of patients. The first cohort consisted of research-based patients who underwent PET scans as part of the initial workup for diffuse large B-cell lymphoma (DLBCL). The second cohort consisted of patients who underwent PET scans as part of the evaluation of miscellaneous cancers in clinical routine. In both cohorts, we assessed the correlation between manually and automatically segmented total metabolic tumor volumes (TMTVs), and the overlap between both segmentations (Dice score). For the research cohort, we also compared the prognostic value for progression-free survival (PFS) and overall survival (OS) of manually and automatically obtained TMTVs.
Results: For the first cohort (research cohort), data from 119 patients were retrospectively analyzed. The median Dice score between automatic and manual segmentations was 0.65. The intraclass correlation coefficient between automatically and manually obtained TMTVs was 0.68. Both TMTV results were predictive of PFS (hazard ratio: 2.1 and 3.3 for automatically based and manually based TMTVs, respectively) and OS (hazard ratio: 2.4 and 3.1 for automatically based and manually based TMTVs, respectively). For the second cohort (routine cohort), data from 430 patients were retrospectively analyzed. The median Dice score between automatic and manual segmentations was 0.48. The intraclass correlation coefficient between automatically and manually obtained TMTVs was 0.61.
Conclusion: The TMTVs determined for the research cohort remain predictive of total and PFS for DLBCL. However, the segmentations and TMTVs determined automatically by the algorithm need to be verified and, sometimes, corrected to be similar to the manual segmentation.
Copyright © 2021 Pinochet, Eude, Becker, Shah, Sibille, Toledano, Modzelewski, Vera and Decazes.

Entities:  

Keywords:  artificial intelligence-AI; convolutional neural network; diffuse large B cell lymphoma (DLBCL); fluorodeoxyglucose (18F-FDG); positron emission tomography

Year:  2021        PMID: 33718406      PMCID: PMC7953145          DOI: 10.3389/fmed.2021.628179

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  33 in total

1.  Lung Cancer Recurrence: 18F-FDG PET/CT in Clinical Practice.

Authors:  Asha Kandathil; Robert Carson Sibley; Rathan M Subramaniam
Journal:  AJR Am J Roentgenol       Date:  2019-07-30       Impact factor: 3.959

2.  Observer variation in interpreting 18F-FDG PET/CT findings for lymphoma staging.

Authors:  Michael S Hofman; Nigel C Smeeton; Sheila C Rankin; Tom Nunan; Michael J O'Doherty
Journal:  J Nucl Med       Date:  2009-09-16       Impact factor: 10.057

3.  Development of a generic thresholding algorithm for the delineation of 18FDG-PET-positive tissue: application to the comparison of three thresholding models.

Authors:  S Vauclin; K Doyeux; S Hapdey; A Edet-Sanson; P Vera; I Gardin
Journal:  Phys Med Biol       Date:  2009-10-28       Impact factor: 3.609

4.  Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma.

Authors:  Domenico Albano; Giovanni Bosio; Nicola Bianchetti; Chiara Pagani; Alessandro Re; Alessandra Tucci; Raffaele Giubbini; Francesco Bertagna
Journal:  Ann Nucl Med       Date:  2019-03-30       Impact factor: 2.668

Review 5.  PET/CT for Evaluation of Ovarian Cancer.

Authors:  Jukka Kemppainen; Johanna Hynninen; Johanna Virtanen; Marko Seppänen
Journal:  Semin Nucl Med       Date:  2019-07-04       Impact factor: 4.446

Review 6.  PET/CT for Patients With Breast Cancer: Where Is the Clinical Impact?

Authors:  Gary A Ulaner
Journal:  AJR Am J Roentgenol       Date:  2019-05-07       Impact factor: 3.959

Review 7.  Clinical role of FDG PET in evaluation of cancer patients.

Authors:  Lale Kostakoglu; Harry Agress; Stanley J Goldsmith
Journal:  Radiographics       Date:  2003 Mar-Apr       Impact factor: 5.333

8.  Observer variation in FDG PET-CT for staging of non-small-cell lung carcinoma.

Authors:  Michael S Hofman; Nigel C Smeeton; Sheila C Rankin; Tom Nunan; Michael J O'Doherty
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10-01       Impact factor: 9.236

Review 9.  PET/CT in Lymphoma: Current Overview and Future Directions.

Authors:  Bruce D Cheson
Journal:  Semin Nucl Med       Date:  2017-10-02       Impact factor: 4.446

10.  18F-FDG PET/CT Uptake Classification in Lymphoma and Lung Cancer by Using Deep Convolutional Neural Networks.

Authors:  Ludovic Sibille; Robert Seifert; Nemanja Avramovic; Thomas Vehren; Bruce Spottiswoode; Sven Zuehlsdorff; Michael Schäfers
Journal:  Radiology       Date:  2019-12-10       Impact factor: 11.105

View more
  5 in total

Review 1.  Artificial Intelligence in Lymphoma PET Imaging:: A Scoping Review (Current Trends and Future Directions).

Authors:  Navid Hasani; Sriram S Paravastu; Faraz Farhadi; Fereshteh Yousefirizi; Michael A Morris; Arman Rahmim; Mark Roschewski; Ronald M Summers; Babak Saboury
Journal:  PET Clin       Date:  2022-01

Review 2.  Artificial intelligence with deep learning in nuclear medicine and radiology.

Authors:  Milan Decuyper; Jens Maebe; Roel Van Holen; Stefaan Vandenberghe
Journal:  EJNMMI Phys       Date:  2021-12-11

3.  Prognostic value of baseline metabolic tumour volume in advanced-stage Hodgkin's lymphoma.

Authors:  Pierre Pinochet; Edgar Texte; Aspasia Stamatoullas-Bastard; Pierre Vera; Sorina-Dana Mihailescu; Stéphanie Becker
Journal:  Sci Rep       Date:  2021-12-01       Impact factor: 4.379

4.  Automatic classification of lymphoma lesions in FDG-PET-Differentiation between tumor and non-tumor uptake.

Authors:  Thomas W Georgi; Axel Zieschank; Kevin Kornrumpf; Lars Kurch; Osama Sabri; Dieter Körholz; Christine Mauz-Körholz; Regine Kluge; Stefan Posch
Journal:  PLoS One       Date:  2022-04-18       Impact factor: 3.240

5.  Automated classification of PET-CT lesions in lung cancer: An independent validation study.

Authors:  Pablo Borrelli; José Luis Loaiza Góngora; Reza Kaboteh; Olof Enqvist; Lars Edenbrandt
Journal:  Clin Physiol Funct Imaging       Date:  2022-07-07       Impact factor: 2.121

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.